DIM
EDIT icon

DLK Investment Management’s Editas Medicine EDIT Stock Holding History

DLK Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$42.7K Sell
16,619
-1,083
-6% -$3.17K 0.02% 91
2026
Q2 		$82.7K Buy
17,702
+1,083
+7% +$3.17K 0.04% 82
2026
Q1 		$41K Hold
16,619
– – 0.02% 86
2025
Q4 		$34.1K Sell
16,619
-12,700
-43% -$36.7K 0.01% 85
2025
Q3 		$102K Sell
29,319
-1,400
-5% -$3.91K 0.04% 78
2025
Q2 		$67.6K Hold
30,719
– – 0.03% 78
2025
Q1 		$35.6K Buy
30,719
+5,000
+19% +$7.36K 0.01% 79
2024
Q4 		$32.7K Buy
25,719
+6,517
+34% +$16.6K 0.01% 81
2024
Q3 		$65.5K Buy
19,202
+1,500
+8% +$6.53K 0.03% 95
2024
Q2 		$82.7K Buy
17,702
+1,000
+6% +$5.64K 0.03% 85
2024
Q1 		$124K Hold
16,702
– – 0.05% 80
2023
Q4 		$169K Buy
+16,702
New +$147K 0.08% 75

Other funds holding EDIT

GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

DLK Investment Management's EDIT Position: Q3 2026 in Review

DLK Investment Management reduced its Editas Medicine (EDIT) stake by 6.1% in Q3 2026, selling an estimated $3.17K and leaving 16,619 shares worth $42.7K. The position accounts for 0.02% of the portfolio, ranked #91.

DLK Investment Management first reported a position in EDIT in Q4 2023 and has held it in 12 quarters since. The position peaked at $169K in Q4 2023. 7 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • DLK Investment Management held 16,619 shares of Editas Medicine worth $42.7K as of Q3 2026.
  • DLK Investment Management sold 1,083 Editas Medicine shares in Q3 2026, an estimated $3.17K.
  • Editas Medicine made up 0.02% of DLK Investment Management's portfolio in Q3 2026, its #91 holding.
  • DLK Investment Management first reported a position in Editas Medicine in Q4 2023 and has held it in 12 quarters since.
  • DLK Investment Management's Editas Medicine position peaked at $169K in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on DLK Investment Management's 13F filing for Q3 2026, filed 9 Oct 2026.